Quark partners with leading Polish mutual and pension funds to make direct investments in NASDAQ and NYSE life science companies with promising growth potential.
This enables North American companies to broaden their investor base to European institutional investors, as well as help increase liquidity and potential valuation.
Quark’s institutional investment partners tend to be patient investors with long term investment horizons.
A capital raise with Polish institutional investors is often significantly more attractive in terms of both speed and pricing versus typical North American transactions. Quark and its partners typically invest in straight common equity without warrants or convertible preferred shares. Quark is usually able to close transactions very rapidly with a minimum of cost and red tape.
There are over 378 billion PLN in assets under management in Polish mutual funds and pension funds (over 75 billion USD).